The biopharmaceutical industry is grappling with a profound challenge: the silent erosion of critical process knowledge, particularly "tacit knowledge," during…
Read More
As cell therapies scale and CDMOs cut staff, process know-how is often getting lost in tech transfer
The pharmaceutical industry, particularly the rapidly evolving biopharmaceutical sector, faces a silent but significant challenge: the erosion of critical "tacit…
Read More
Virginia Tech Research Challenges Long Standing Assumptions in Cerebellar Movement Disorder Studies
New research conducted by neuroscientists at the Fralin Biomedical Research Institute at VTC has fundamentally questioned a decades-old paradigm regarding…
Read More
As Cell Therapies Scale and CDMOs Cut Staff, Process Know-How Is Often Getting Lost in Tech Transfer
The biopharmaceutical industry is grappling with a critical challenge: the silent erosion of invaluable "tacit knowledge" during technology transfer processes.…
Read More
Virginia Tech Research Challenges Longstanding Models of Neurological Movement Disorders and the Predictive Power of Purkinje Cells
A paradigm-shifting study led by neuroscientists at the Fralin Biomedical Research Institute at VTC has upended decades of conventional wisdom…
Read More
A Fleet of High-Tech Gadgets and Robots Deployed in Remote Greenland to Study Ice Melt in Unprecedented Detail
This summer, a sophisticated arsenal of high-tech gadgets and autonomous robots will be deployed to the remote and treacherous frontiers…
Read More
Virginia Tech Research Challenges Long Standing Assumptions in Cerebellar Movement Disorder Studies
New research emerging from the Fralin Biomedical Research Institute at VTC is fundamentally questioning the established framework used to study…
Read More
Navigating the Knowledge Gap: How Workforce Shifts and Advanced Therapies Threaten Biopharma’s Critical Tech Transfer Process
The intricate world of biopharmaceutical manufacturing is currently grappling with a silent, yet profoundly impactful, challenge: the erosion of tacit…
Read More
A targeted paper shredder for the genome: new CRISPR tech tears up diseased cells’ DNA
This innovative CRISPR platform leverages a recently identified nuclease called Cas12a2, a protein capable of orchestrating RNA-triggered DNA shredding to…
Read More
As cell therapies scale and CDMOs cut staff, process know-how is often getting lost in tech transfer
The biopharmaceutical industry, in its relentless pursuit of innovation and efficiency, faces a silent but profound challenge: the erosion of…
Read MoreYOU MAY HAVE MISSED
